TORONTO, Oct. 19, 2020 /CNW/ – NeuPath Health Inc. (TSX-V:NPTH) (formerly Klinik Health Ventures Corp.) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, is pleased to announce that it has entered into an agreement with Stifel GMP as co-lead underwriter and sole bookrunner and INFOR Financial Inc. as co-lead underwriter, together with a syndicate of underwriters including Haywood Securities Inc. (collectively, the “Underwriters”), which have agreed to purchase, on a “bought deal” basis 8,890,000 units (the “Units”) of the Company at a price of $0.90 per Unit, for aggregate gross proceeds of $8,001,000.